Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistance
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-6405
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistance ; volume:20 ; number:1 ; day:5 ; month:1 ; year:2023 ; pages:1-11 ; date:12.2023
AIDS research and therapy ; 20, Heft 1 (5.1.2023), 1-11, 12.2023
- Urheber
-
Salata, Robert A.
Grinsztejn, Beatriz
Ritz, Justin
Collier, Ann C.
Hogg, Evelyn
Gross, Robert
Godfrey, Catherine
Kumarasamy, Nagalingeswaran
Kanyama, Cecilia
Mellors, John W.
Wallis, Carole L.
Hughes, Michael D.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12981-022-00494-9
- URN
-
urn:nbn:de:101:1-2023031421022020007134
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Salata, Robert A.
- Grinsztejn, Beatriz
- Ritz, Justin
- Collier, Ann C.
- Hogg, Evelyn
- Gross, Robert
- Godfrey, Catherine
- Kumarasamy, Nagalingeswaran
- Kanyama, Cecilia
- Mellors, John W.
- Wallis, Carole L.
- Hughes, Michael D.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Virologic suppression in response to antiretroviral therapy despite extensive resistance within HIV-1 reverse transcriptase after the first virologic failure
Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria
Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon
Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study
Virologic, immunologic and clinical response of infants to antiretroviral therapy in Kampala, Uganda
Virologic outcomes of second-line antiretroviral therapy in Eastern European country of Georgia
Virologic failure and metabolic syndrome in patients with HIV infection
Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda
High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited setting
Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children
Nachbetreuung von PatientInnen mit „sustained virologic response“
Predictors of suboptimal CD4 response among women achieving virologic suppression in a randomized antiretroviral treatment trial, Africa
Virologic suppression in response to antiretroviral therapy despite extensive resistance within HIV-1 reverse transcriptase after the first virologic failure
Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria
Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon
Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study
Virologic, immunologic and clinical response of infants to antiretroviral therapy in Kampala, Uganda
Virologic outcomes of second-line antiretroviral therapy in Eastern European country of Georgia
Virologic failure and metabolic syndrome in patients with HIV infection
Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda
High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited setting
Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children
Nachbetreuung von PatientInnen mit „sustained virologic response“
Predictors of suboptimal CD4 response among women achieving virologic suppression in a randomized antiretroviral treatment trial, Africa
Virologic suppression in response to antiretroviral therapy despite extensive resistance within HIV-1 reverse transcriptase after the first virologic failure
Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria
Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon
Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study
Virologic, immunologic and clinical response of infants to antiretroviral therapy in Kampala, Uganda
Virologic outcomes of second-line antiretroviral therapy in Eastern European country of Georgia
Virologic failure and metabolic syndrome in patients with HIV infection
Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda
High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited setting
Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children
Nachbetreuung von PatientInnen mit „sustained virologic response“